Commentary on Kehar et al.
作者信息
Ali Huzafa, Ahmad Munaiba, Ima Mahfuja Jahan
机构信息
CMH Multan, Multan, Punjab, Pakistan.
Chittagong Medical College, Chittagong, Bangladesh.
出版信息
Can Liver J. 2025 May 26;8(2):268-269. doi: 10.3138/canlivj-2024-0051. eCollection 2025 May.
Abstract
摘要
相似文献
1
Commentary on Kehar et al.对凯哈尔等人的评论
Can Liver J. 2025 May 26;8(2):268-269. doi: 10.3138/canlivj-2024-0051. eCollection 2025 May.
2
Response to Commentary on Kehar et al.对凯哈尔等人评论的回应
Can Liver J. 2025 May 26;8(2):270-271. doi: 10.3138/canlivj-2024-0057. eCollection 2025 May.
3
Memoir of Kehar S. Chouké 1885-1967.
Trans Stud Coll Physicians Phila. 1969 Jan;36(3):132-3.
4
Challenges and Insights of Cannabis Vaping Among Sexual Minority Individuals: Commentary on Maglalang et al. (2024).性少数群体中大麻雾化的挑战与见解：对马格拉拉格等人（2024年）的评论
Subst Use Misuse. 2025;60(9):1411-1414. doi: 10.1080/10826084.2025.2495777. Epub 2025 Apr 27.
5
Reply to Hertenstein et al.'s commentary on Brupbacher et al.: The effects of exercise on sleep in unipolar depression: A systematic review and network meta-analysis.对赫滕斯坦等人对布鲁帕赫尔等人的评论的回复：运动对单相抑郁症患者睡眠的影响：一项系统评价和网状Meta分析
Sleep Med Rev. 2021 Dec;60:101562. doi: 10.1016/j.smrv.2021.101562. Epub 2021 Oct 29.
6
On Convenience, Diversity, and Generalisability: A Commentary on Scaff et al. (2025).论便利性、多样性与普遍性：对斯卡夫等人（2025年）的评论
Dev Sci. 2025 Sep;28(5):e70050. doi: 10.1111/desc.70050.
7
On the Road to Somewhere: Commentary on Breiner et al., Matheson et al., and Palmer et al.通往某处的道路：对布赖纳等人、马西森等人以及帕尔默等人的评论
Int J Eat Disord. 2025 Jun;58(6):1018-1020. doi: 10.1002/eat.24402. Epub 2025 Mar 10.
8
Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA.对注意力缺陷多动障碍多模式治疗研究（MTA）评论的回应：挖掘MTA的意义
J Abnorm Child Psychol. 2002 Aug;30(4):327-32. doi: 10.1023/a:1015709706388.
9
Caution with PBPK Modeling Based on the In Vitro Kinetics for Bilirubin Hepatic Uptake and Glucuronidation: Commentary on Dong et al.基于胆红素肝脏摄取和葡萄糖醛酸化体外动力学的生理药代动力学模型的注意事项：对董等人的评论
Clin Pharmacol Ther. 2025 Aug;118(2):301-303. doi: 10.1002/cpt.3734. Epub 2025 May 26.
10
Reply to L. Lucchino et al. on commentary on "Histologic correlates of "Choroidal Abnormalities" in Neurofibromatosis type 1".对L. Lucchino等人关于“1型神经纤维瘤病中‘脉络膜异常’的组织学相关性”评论的回复。
Acta Neuropathol. 2024 Aug 16;148(1):23. doi: 10.1007/s00401-024-02782-2.
本文引用的文献
1
Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016.非酒精性脂肪性肝病在 2007-2016 年期间美国青少年和年轻人中的流行趋势。
Hepatol Commun. 2021 Oct;5(10):1676-1688. doi: 10.1002/hep4.1760. Epub 2021 Jul 1.
2
Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.美国非酒精性脂肪性肝病患病率、严重程度和结局的种族和民族差异：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2018 Feb;16(2):198-210.e2. doi: 10.1016/j.cgh.2017.09.041. Epub 2017 Sep 29.
3
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.α1抗胰蛋白酶缺乏症的全球种族和民族分布：已发表的遗传流行病学调查分析总结
Chest. 2002 Nov;122(5):1818-29. doi: 10.1378/chest.122.5.1818.
Zotero 插件